Intra-lesional injection of the novel PKC activator EBC-46 rapidly ablates tumors in mouse models.

Por Glen M Boyle, Marjorie M A D'Souza, Carly J Pierce, Ryan A Adams, Aaron S Cantor, Jenny P Johns, Lidia Maslovskaya, Victoria A Gordon, Paul W Reddell, Peter G Parsons
Publicado em 2014-01-01